Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
5,064
Total Claims
$796K
Drug Cost
495
Beneficiaries
$1,608
Cost/Patient
Risk Score Breakdown 41/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
+495%
Opioid rate vs peers
54.7% vs 9.2% avg
+124%
Cost per patient vs peers
$1,608 vs $719 avg
+149%
Brand preference vs peers
16.5% vs 6.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid rate is 495% above Physician Assistant peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
54.7%
Opioid Rate
2,769
Opioid Claims
$441K
Opioid Cost
24.3%
Long-Acting Rate
This provider's opioid prescribing rate of 54.7% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 838 claims · $581K
Generic: 4,226 claims · $215K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl | 102 | $133K |
| Ibuprofen/Famotidine | 19 | $51K |
| Oxycodone Myristate | 45 | $48K |
| Methylnaltrexone Bromide | 14 | $48K |
| Buprenorphine Hcl | 51 | $46K |
| Oxycodone Hcl/Acetaminophen | 394 | $42K |
| Tapentadol Hcl | 33 | $40K |
| Diclofenac Sodium | 66 | $28K |
| Oxycodone Hcl | 866 | $26K |
| Naloxegol Oxalate | 45 | $20K |
| Tapentadol Hcl | 22 | $20K |
| Oxymorphone Hcl | 17 | $16K |
| Morphine Sulfate | 222 | $12K |
| Lidocaine | 63 | $11K |
| Pregabalin | 160 | $8,607 |
Prescribing Profile
47
Unique Drugs
41.0
Anomaly Score
Patient Profile
63
Avg Age
60%
Female
1.70
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About